Halozyme Therapeutics (HALO) Q2 2014 Earnings

12MayConfirmed
Q3 2013
Q4 2013
Q1 2014
Q2 2014
-0.22
-0.19
-0.17
-0.14

Details

Expected EPS
-0.14
Actual EPS
-0.22
Surprise EPS
-0.08
Surprise Percent
+57.14%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.22 per share for Q2 2014.

0 Comments

Share your thoughts